Advances in the etiology of chronic pancreatitis

Digestive Diseases

Volumn 28, Issue 2, 2010, Pages 324-329

  Lerch, Markus M ^a   Mayerle, Julia ^a   Aghdassi, Ali A ^a   Budde, Christoph ^a   Nitsche, Claudia ^a   Sauter, Gabriele ^a   Persike, Maria ^a   Günther, Annett ^a   Simon, Peter ^a   Weiss, F Ulrich ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

Anionic trypsinogen; Cationic trypsinogen; Chronic pancreatitis; Chymotrypsin C; Genetic risk factors; Johanson Blizzard syndrome

Indexed keywords

CALCIUM SENSING RECEPTOR; CATHEPSIN B; CHYMOTRYPSIN; CHYMOTRYPSINOGEN; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSINOGEN; UBIQUITIN PROTEIN LIGASE E3;

ALCOHOL ABUSE; CHRONIC PANCREATITIS; DISEASE COURSE; DISEASE SEVERITY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INHERITANCE; MUTATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ANIMALS; HUMANS; MUTATION; PANCREATITIS, CHRONIC; PROTEINS;

EID: 77956364430     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319408     Document Type: Review

References (27)

1. Halangk W, Krüger B, Ruthenbürger M, Stürzebecher J, Albrecht E, Lippert H, Lerch MM: Trypsin activity is not involved in premature, intrapancreatic trypsinogen activation. Am J Physiol Gastrointest Liver Physiol 2002;282:G367-G374.
2. Howes N, Lerch MM, Greenhalf W, Stocken D, Ellis I, Simon P, Truninger K, Ammann R, Cavallini G, Charnley R, Uomo G, Delhaye M, Spicak J, Drumm B, Jansen J, Mountford R, Whitcomb DC, Neoptolemos JP: Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2004;2:252-261.
3. Keim V, Bauer N, Teich N, Simon P, Lerch MM, Mössner J: Clinical characterization of patients with hereditary pancreatitis and mutations in the cationic trypsinogen gene. Am J Med 2001;111:622-626.
4. Rebours V, Boutron-Ruault MC, Schnee M, Férec C, Le Maréchal C, Hentic O, Maire F, Hammel P, Ruszniew skiP, Lévy P: The nat ural history of hereditary pancreatitis: a national series. Gut 2009;58:97-103.
5. Lowenfels AB, Maisonneuve P, Whitcomb DC, Lerch MM, DiMagno EP: Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA 2001;286:169-170.
6. Ellis I, Lerch MM, Whitcomb DC: Genetic testing for hereditary pancreatitis: guidelines for indications, counselling, consent and privacy issues. Pancreatology 2001;1:405-415.
7. Simon P, Weiss FU, Zimmer K P, Rand S, Brinkmann B, Domschke W, Lerch MM: Spontaneous and sporadic trypsinogen mutations in idiopathic pancreatitis. JAMA 2002;288:2122.
8. Brand RE, Lerch MM, Rubinstein WS, Neoptolemos JP, Whitcomb DC, Hruban RH, Brentnall TA, Lynch HT, Canto MI: Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 2007;56:1460-1469.
9. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, Martin SP, Gates LK Jr, Amann ST, Toskes PP, Liddle R, McGrath K, Uomo G, Post JC, Ehrlich GD: Hereditary pa ncreat itis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996;14:141-145.
10. Simon P, Weiss FU, Sahin-Toth M, Parry M, Nayler O, Lenfers B, Schnekenburger J, Mayerle J, Domschke W, Lerch MM: Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122-> Cys) that alters autoactivation and autodegradation of cationic trypsinogen. J Biol Chem 2002;277:5404-5410.
11. Teich N, Le Maréchal C, Kukor Z, Caca K, Witzigmann H, Chen JM, Tóth M, Mössner J, Keim V, Férec C, Sahin-Tóth M: Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2). Hum Mutat 2004;23:22-31.
12. Weiss FU, Zenker M, Ekici AB, Simon P, Mayerle J, Lerch MM: Local clustering of PRSS1 R122H mutations in hereditary pancreatitis patients from Northern Germany. Am J Gastroenterol 2008;103:2585-2588.
13. Kukor Z, Mayerle J, Krüger B, Tóth M, Steed PM, Halangk W, Lerch MM, Sahin-Tóth M: Presence of cathepsin B in the human pancreatic secretory pathway and its role in trypsinogen activation during hereditary pancreatitis. J Biol Chem 2002;277:21389-21396.
14. Le Maréchal C, Masson E, Chen JM, Morel F, Ruszniewski P, Levy P, Férec C: Hereditary pancreatitis caused by triplication of the trypsinogen locus. Nat Genet 2006;38:1372-1374.
15. Kereszturi E, Szmola R, Kukor Z, Simon P, Weiss FU, Lerch MM, Sahin-Tóth M: Hereditary pancreatitis caused by mutationinduced misfolding of human cationic trypsinogen: a novel disease mechanism. Hum Mutat 2009;30:575-5 82.
16. Witt H, Sahin-Toth M, Landt O, Chen JM, Kahne T, Drenth JP, Kukor Z, Szepessy E, Halangk W, Dahm S, Rohde K, Schulz HU, Le Marechal C, Akar N, Ammann RW, Truninger K, Bargetzi M, Bhatia E, Castellani C, Cavestro GM, Cerny M, Destro-Bisol G, Spedini G, Eiberg H, Jansen JB, Koudova M, Rausova E, Macek M Jr, Malats N, Real FX, Menzel HJ, Moral P, Galavotti R, Pignatti PF, Rickards O, Spicak J, Zarnescu NO, Bock W, Gress TM, Friess H, Ockenga J, Schmidt H, Pfutzer R, Lohr M, Simon P, Weiss FU, Lerch MM, Teich N, Keim V, Berg T, Wiedenmann B, Luck W, Groneberg DA, Becker M, Keil T, Kage A, Bernardova J, Braun M, Guldner C, Halangk J, Rosendahl J, Witt U, Treiber M, Nickel R, Ferec C: A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet 2006;38:668-673.
17. Rosendahl J, Witt H, Szmola R, Bhatia E, Ozsvári B, Landt O, Schulz HU, Gress TM, Pfützer R, Löhr M, Kovacs P, Blüher M, Stumvoll M, Choudhuri G, Hegyi P, te Morsche RH, Drenth JP, Truninger K, Macek M Jr, Puhl G, Witt U, Schmidt H, Büning C, Ockenga J, Kage A, Groneberg DA, Nickel R, Berg T, Wiedenmann B, Bödeker H, Keim V, Mössner J, Teich N, Sahin-Tóth M: Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet 2008;40:78-82.
18. Witt H, Luck W, Hennies HC, Classen M, Kage A, Lass U, Landt O, Becker M: Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000;25:213-216.
19. Weiss FU, Simon P, Witt H, Mayerle J, Hlouschek V, Zimmer KP, Schnekenburger J, Domschke W, Neoptolemos JP, Lerch MM: SPINK1 mutations and phenotypic expression in patients with pancreatitis associated with trypsinogen mutations. J Med Genet 2003;40:e40.
20. Mahurkar S, Idris MM, Reddy DN, Bhaskar S, Rao GV, Thomas V, Singh L, Chandak GR: Association of cathepsin B gene polymorphisms with tropical calcific pancreatitis. Gut 2006;55:1270-1275.
21. Weiss FU, Behn CO, Simon P, Ruthenbürger M, Halangk W, Lerch MM: Cathepsin B gene polymorphism Val26 is not associated with idiopathic chronic pancreatitis in European patients. Gut 2007;56:1322-1323.
22. Krüger B, Albrecht E, Lerch MM: The role of intracellular calcium signaling in premature protease activation and the onset of pancreatitis. Am J Pathol 2000;157:43-50.
23. Pearce SH, Wooding C, Davies M, Tollefsen SE, Whyte MP, Thakker RV: Calcium-sensing receptor mutations in familial hypocalciuric hypercalcaemia with recurrent pancreatitis. Clin Endocrinol (Oxf) 1996;45:675-680.
24. Felderbauer P, Klein W, Bulut K, Ansorge N, Dekomien G, Werner I, Epplen JT, Schmitz F, Schmidt WE: Mutations in the calciumsensing receptor: a new genetic risk factor for chronic pancreatitis? Scand J Gastroenterol 2006;41:343-348.
25. Weiss FU, Simon P, Bogdanova N, Mayerle J, Dworniczak B, Horst J, Lerch MM: Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls. Gut 2005;54:1456-1460.
26. Weiss FU, Simon P, Bogdanova N, Shcheynikov N, Muallem S, Lerch MM: Functional characterisation of the CFTR mutations M348V and A1087P from patients with pancreatitis suggests functional interaction between CFTR monomers. Gut 2009;58:733-734.
27. Zenker M, Mayerle J, Lerch MM, Tagariello A, Zerres K, Durie PR, Beier M, Hülskamp G, Guzman C, Rehder H, Beemer FA, Hamel B, Vanlieferinghen P, Gershoni-Baruch R, Vieira MW, Dumic M, Auslender R, Gil-Da-Silva-Lopes VL, Steinlicht S, Rauh M, Shalev SA, Thiel C, Winterpacht A, Kwon YT, Varshavsky A, Reis A: Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome). Nat Genet 2005;37:1345-1350.